NIH-funded research R21 grant

Understanding how age affects cognitive function in patients after stem cell and CAR-T treatments

Official title: Exploring Age Differences in Patient Reported Cognitive Function Trajectories among Hematopoietic Stem Cell Transplant and Chimeric Antigen Receptor T-cell patients and Linking Two Key Measures

Funded at Medical College of Wisconsin · NIH-10593018 · Data updated 2026-11-12

This study is looking at how memory and thinking skills change over time for people who have had stem cell or CAR-T therapy, especially focusing on how these changes might be different for younger and older patients, and it will use feedback from patients to understand their experiences better.

Quick facts

Grant typeR21 grant
Study typeNIH-funded research
Funding institutionMedical College of Wisconsin
NIH-funded
Lab location1 site (Milwaukee, United States)
Project startSeptember 15, 2023
Project endAugust 31, 2025
Funding year2023
Award (this year)$429,000
NIH project number1R21AG077024-01A1
Project IDNIH-10593018 on NIH RePORTER

Who could benefit from this research

Could help

Ideal candidates for this research include older adults who have received HCT or CAR-T therapy for hematologic diseases.

Less likely to help

Patients who are younger than 21 years old or those who have not undergone HCT or CAR-T therapy may not benefit from this research.

What this research studies

This research investigates the cognitive function trajectories of patients who have undergone hematopoietic stem cell transplantation (HCT) and Chimeric Antigen Receptor T-cell (CAR-T) therapy, focusing on how these trajectories differ by age. It emphasizes the importance of patient-reported outcomes (PROs), which capture patients' own assessments of their symptoms and functioning. By utilizing a large clinical registry, the study aims to gather more representative data on cognitive dysfunction, particularly among older and diverse patient populations. The research will employ the Patient-Reported Outcomes Measurement Information System (PROMIS) to assess cognitive function and its variations across different age groups.

Why it matters

Potential benefit: If successful, this research could lead to improved understanding and management of cognitive dysfunction in older patients undergoing HCT and CAR-T treatments.

How similar studies have gone: Previous research has shown that understanding patient-reported outcomes can significantly enhance treatment approaches, indicating potential success for this study's methodology.

Where this research is happening

  • Medical College of Wisconsin
    Milwaukee, United States
    Active

Researchers

  • Principal investigator: Cusatis, Rachel Nicole — Medical College of Wisconsin
  • Study coordinator: Cusatis, Rachel Nicole

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.